Naltrexone for treatment of impaired awareness of hypoglycemia in type 1 diabetes: A randomized clinical trial

AIMS: Impaired awareness of hypoglycemia (IAH) is a limiting factor in the treatment of type 1 diabetes (T1D) and is a challenging condition to reverse. The objective of this study was to test the hypothesis that naltrexone therapy in subjects with T1D and IAH will improve counterregulatory hormone...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Diabetes Complications
Autori principali: Moheet, Amir, Mangia, Silvia, Kumar, Anjali, Tesfaye, Nolawit, Eberly, Lynn E, Bai, Yun, Kubisiak, Kristine, Seaquist, Elizabeth R
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4871128/
https://ncbi.nlm.nih.gov/pubmed/26345338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jdiacomp.2015.08.004
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi